Prolight Diagnostics AB (publ) (NGM:PRLD)

Market Cap	351.04M
Revenue (ttm)	36.37M
Net Income (ttm)	-26.94M
Shares Out	702.09M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,445,610
Average Volume	4,811,494
Open	n/a
Previous Close	0.440
Day's Range	n/a
52-Week Range	0.117 - 0.500
Beta	2.75
RSI	83.58
Earnings Date	Feb 21, 2025

About Prolight Diagnostics AB

Prolight Diagnostics AB (publ) develops diagnostic systems used in point of care testing in Sweden. It engages in the development of PLD micro flex and flex membrane. Prolight Diagnostics AB (publ) was incorporated in 1999 and is based in Stockholm, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 16
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: PRLD

Financial Performance

In 2023, Prolight Diagnostics AB's revenue was 24.22 million, a decrease of -31.35% compared to the previous year's 35.27 million. Losses were -135.46 million, 1003.5% more than in 2022.